ICA 2021 | Dalian, China

Introduction to ICA-2021

The Annual International Congress of Antibodies (ICA), initiated from 2009, had been successfully organized in Beijing, Hangzhou Dalian and Nanjing, attracted more than 3,500 participants from 60 countries. ICA series congresses contribute to offering professionals in the field of antibody a multidisciplinary informative cooperative platform, and it has been the most definite and grand Antibody event in Asia. The ICA-2021 will be held during September 25-27, 2021 at Dalian International Conference Center, China.


Programmed Chapters at a Glance


Renowned Speakers of Previous Events

Dr. Bruce A. Beutler,

Professor, UT Southwestern, USA
Nobel Prize laureate in Physiology or Medicine, 2011

Dr. Tim Hunt,

Emeritus Group Leader, Clare Hall Laboratories, UK
Nobel Prize laureate in Physiology or Medicine, 2001

Dr. Steven J. Swanson,

Senior Vice President, ImmunoCellular Therapeutics, Ltd., USA

Dr. Mitchell Ho,

Senior Investigator, National Cancer Institute, NIH, USA

Dr. Thomas J. Webster,

Art Zafirpoulo Chair, Chair Department of Chemical Engineering, Northeastern University, USA

Ms. Robin Barbour,

Head, Prothena Corporation, USA

Dr. Jing Li,

Senior Vice President, WuXi Biologics, China

Dr. William R. Alley,

Jr., Senior Scientist, Waters Corp., USA

Dr. Eric Risser,

Senior Vice President, MacroGenics, Inc., USA

Dr. Madi R. Madiyalakan,

CEO, Quest PharmaTech Inc., Canada

Dr. Weikang Tao,

Vice President and CEO of R&D Center, Jiangsu Henrui Medicine Co., Ltd., China

Dr. Esther Una Cidon,

Professor, Royal Bournemouth Hospital, UK

Ms. Ningling Wang,

Managing Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, China

Dr. Z. Ying Li,

Partner, Steptoe & Johnson LLP, USA

Dr. Weiping Shao,

Director, Regeneron Pharmaceuticals, Inc., USA

Dr. Lidia Anna Retkowska-Mika, 

Director, Office for Registration of Medicinal Products, Medical Devices and Biocides, Poland

Dr. Ulrich Storz,

 Senior Partner, Michalski•Hüttermann & Partner, Germany

Dr. George Lovrecz,

Adjunct Professor, RMIT University, Australia

Ms. Xingmei Tan,

Senior Engineer, Abcam(Hangzhou)Biotechnology Co. Ltd., China

Dr. Mark I. Fitchmun,

President and Senior Advisor, Somatek. Inc., USA

Dr. Nirmesh Shah,

Director, Apobiologix, USA

Dr. Matthew F. Heil,

Chief Scientific Officer, Curemark LLC, USA

Dr. Carole Schante,

Principal Scientist, Novartis, Switzerland

Dr. Marcus Mreyen,

Director, Protagen Protein Services GmbH, Germany

Dr. Candida Fratazzi,

 President, BBCR Consulting, USA

Dr. Shawn Guse,

President and CEO, Intuitive Biosciences, USA

Dr. Abhishek Saharia,

Director, DiscoveRx Corporation, USA

Dr. David Franco,

Head, GSK Vaccines, Belgium

Dr. Hui Zhao, 

Principal Scientist, Agensys, USA

Dr. Xianbin Yang,

Director of R & D, AM Biotechnologies, USA

Dr. Steve Xiaofeng Yu, 

Director, Cyagen Biosciences, Inc, China

Dr. Patrick Liu,

Vice President, Teva Pharmaceuticals Ltd., USA

Dr. Martin Welschof,

CEO, Opsona Therapeutics Ltd, Ireland

Dr. Matthias Germer,

Senior Director, Biotest AG, Germany

Dr. William L. Klein, 

Professor, University of California - Los Angeles, USA

Dr. Kevin Heyries,

Co-Founder, AbCellera, Canada



● ICA-2021 is one of the most effective international marketing platforms in the field of life science and biomedicine, which offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity.

● The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.

More More
Online Registration
News Released
Speaking Proposals Are          Now Being Accepted
Call for Exhibitors and          Sponsors
Call for Collaborative
World Class Meeting Venue

ICA-2021 will be celebrated at Dalian International Conference Center, China

Operating Organizations

BIT Congress Inc.
©2009-2021 All rights reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629